Rs 400 Crore Investment Planned By Granules India
Pharmaceutical company, Granules India Limited has planned to invest Rs 400 crore over the next 2 years to backward integrate its key products and set up a greenfield formulation facility near Hyderabad. The firm is in the midst of capacity expansion which will take its tablet capacity from 23-24 billion to around 29 billion.
Out of the total investment of Rs 400 crore about Rs 250 crore would go on its backward integration and Rs 50 crore on its greenfield formulation manufacturing unit in Genome Valley, Hyderabad.
Also Read: J&K To Get Light Metro Rail